MYCN and neuroblastoma: Indeed, emerging evidences have shown that MYCN drives an immunosuppressive environment, including reduced natural killer (NK) cell cytotoxicity, dysfunctional T‐cell profile, and immunosuppressive myeloid population, these impair anti‐tumor immunity and impact NB patient survival [11, 12].